Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
BA.5.1.10SYoung-STATACATGTCTCTGGGACCA20452176321782F-13305.5Singapore
BF.41SYoung-STATACATGTCTCTGGGACCA20452176321782F-13305.5Singapore
BA.5.1.2SYoung-STATACATGTCTCTGGGACCA20452176321782F-13305.5Singapore
BF.36SYoung-STATACATGTCTCTGGGACCA20452176321782F-13305.5Singapore
BF.12SYoung-STATACATGTCTCTGGGACCA20452176321782F-13305.5Singapore
BF.5.4SYoung-STATACATGTCTCTGGGACCA20452176321782F-13305.5Singapore
BQ.1.18SYoung-STATACATGTCTCTGGGACCA20452176321782F-13305.5Singapore
BF.5.1SYoung-STATACATGTCTCTGGGACCA20452176321782F-13305.5Singapore
BA.5.1.3SYoung-STATACATGTCTCTGGGACCA20452176321782F-13305.5Singapore
BA.5.1.23SYoung-STATACATGTCTCTGGGACCA20452176321782F-13305.5Singapore
BF.8SYoung-STATACATGTCTCTGGGACCA20452176321782F-13305.5Singapore
BA.5.2.28SYoung-STATACATGTCTCTGGGACCA20452176321782F-13305.5Singapore
BA.5.2.62SYoung-STATACATGTCTCTGGGACCA20452176321782F-13305.5Singapore
BA.5.2.24SYoung-STATACATGTCTCTGGGACCA20452176321782F-13305.5Singapore
BA.5.8SYoung-STATACATGTCTCTGGGACCA20452176321782F-13305.5Singapore
BF.28SYoung-STATACATGTCTCTGGGACCA20452176321782F-13305.5Singapore
BA.5.1.1SYoung-STATACATGTCTCTGGGACCA20452176321782F-13305.5Singapore
BE.1.1.1SYoung-STATACATGTCTCTGGGACCA20452176321782F-13305.5Singapore
XAZSYoung-STATACATGTCTCTGGGACCA20452176321782F-13305.5Singapore
BE.4SYoung-STATACATGTCTCTGGGACCA20452176321782F-13305.5Singapore
BA.5.1.24SYoung-STATACATGTCTCTGGGACCA20452176321782F-13305.5Singapore
BA.5.1.16SYoung-STATACATGTCTCTGGGACCA20452176321782F-13305.5Singapore
BA.5.2.26SYoung-STATACATGTCTCTGGGACCA20452176321782F-13305.5Singapore
BA.5.2.2SYoung-STATACATGTCTCTGGGACCA20452176321782F-13305.5Singapore
BA.4.1.4SYoung-STATACATGTCTCTGGGACCA20452176321782F-13305.5Singapore
BQ.1.8.2SYoung-STATACATGTCTCTGGGACCA20452176321782F-13305.5Singapore
EC.1.1SYoung-STATACATGTCTCTGGGACCA20452176321782F-13305.5Singapore
BA.5.1.31SYoung-STATACATGTCTCTGGGACCA20452176321782F-13305.5Singapore
BA.5.2.30SYoung-STATACATGTCTCTGGGACCA20452176321782F-13305.5Singapore
CG.1SYoung-STATACATGTCTCTGGGACCA20452176321782F-13305.5Singapore
BA.5.2.16SYoung-STATACATGTCTCTGGGACCA20452176321782F-13305.5Singapore
BQ.1.20SYoung-STATACATGTCTCTGGGACCA20452176321782F-13305.5Singapore
BF.7.11SYoung-STATACATGTCTCTGGGACCA20452176321782F-13305.5Singapore
CE.1SYoung-STATACATGTCTCTGGGACCA20452176321782F-13305.5Singapore
EA.1SYoung-STATACATGTCTCTGGGACCA20452176321782F-13305.5Singapore
DH.1SYoung-STATACATGTCTCTGGGACCA20452176321782F-13305.5Singapore
BF.6SYoung-STATACATGTCTCTGGGACCA20452176321782F-13305.5Singapore
BQ.1.17SYoung-STATACATGTCTCTGGGACCA20452176321782F-13305.5Singapore
CC.1SYoung-STATACATGTCTCTGGGACCA20452176321782F-13305.5Singapore
BZ.1SYoung-STATACATGTCTCTGGGACCA20452176321782F-13305.5Singapore
CK.2SYoung-STATACATGTCTCTGGGACCA20452176321782F-13305.5Singapore
BF.13SYoung-STATACATGTCTCTGGGACCA20452176321782F-13305.5Singapore
BA.5.1.4SYoung-STATACATGTCTCTGGGACCA20452176321782F-13305.5Singapore
BA.5.1.34SYoung-STATACATGTCTCTGGGACCA20452176321782F-13305.5Singapore
BQ.1.6SYoung-STATACATGTCTCTGGGACCA20452176321782F-13305.5Singapore
BA.5.2.36SYoung-STATACATGTCTCTGGGACCA20452176321782F-13305.5Singapore
BV.1SYoung-STATACATGTCTCTGGGACCA20452176321782F-13305.5Singapore
BF.26SYoung-STATACATGTCTCTGGGACCA20452176321782F-13305.5Singapore
BA.5.1.33SYoung-STATACATGTCTCTGGGACCA20452176321782F-13305.5Singapore
CP.5SYoung-STATACATGTCTCTGGGACCA20452176321782F-13305.5Singapore
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used